• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

错综复杂:纤维蛋白溶解系统与先天免疫系统的相互作用。

All tangled up: interactions of the fibrinolytic and innate immune systems.

作者信息

Whyte Claire S

机构信息

Aberdeen Cardiovascular and Diabetes Centre, The Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.

出版信息

Front Med (Lausanne). 2023 Jun 2;10:1212201. doi: 10.3389/fmed.2023.1212201. eCollection 2023.

DOI:10.3389/fmed.2023.1212201
PMID:37332750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10272372/
Abstract

The hemostatic and innate immune system are intertwined processes. Inflammation within the vasculature promotes thrombus development, whilst fibrin forms part of the innate immune response to trap invading pathogens. The awareness of these interlinked process has resulted in the coining of the terms "thromboinflammation" and "immunothrombosis." Once a thrombus is formed it is up to the fibrinolytic system to resolve these clots and remove them from the vasculature. Immune cells contain an arsenal of fibrinolytic regulators and plasmin, the central fibrinolytic enzyme. The fibrinolytic proteins in turn have diverse roles in immunoregulation. Here, the intricate relationship between the fibrinolytic and innate immune system will be discussed.

摘要

止血系统和先天免疫系统是相互交织的过程。血管内的炎症促进血栓形成,而纤维蛋白是先天免疫反应的一部分,用于捕获入侵的病原体。对这些相互关联过程的认识导致了“血栓炎症”和“免疫血栓形成”这两个术语的出现。一旦形成血栓,就由纤维蛋白溶解系统来溶解这些凝块并将它们从血管中清除。免疫细胞含有一系列纤维蛋白溶解调节因子和纤溶酶(核心纤维蛋白溶解酶)。反过来,纤维蛋白溶解蛋白在免疫调节中具有多种作用。在此将讨论纤维蛋白溶解系统与先天免疫系统之间的复杂关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8183/10272372/2c09f948f368/fmed-10-1212201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8183/10272372/2c09f948f368/fmed-10-1212201-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8183/10272372/2c09f948f368/fmed-10-1212201-g001.jpg

相似文献

1
All tangled up: interactions of the fibrinolytic and innate immune systems.错综复杂:纤维蛋白溶解系统与先天免疫系统的相互作用。
Front Med (Lausanne). 2023 Jun 2;10:1212201. doi: 10.3389/fmed.2023.1212201. eCollection 2023.
2
Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation.新冠病毒肺炎中的纤维蛋白溶解:对血凝块溶解及炎症调节的影响
Curr Drug Targets. 2022;23(17):1578-1592. doi: 10.2174/1389450123666221011102250.
3
The fibrinolytic system in man.人类的纤维蛋白溶解系统。
Crit Rev Oncol Hematol. 1986;4(3):249-301. doi: 10.1016/s1040-8428(86)80014-2.
4
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.急性肺损伤中的凝血、纤维蛋白溶解及纤维蛋白沉积
Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB.
5
[Heparin effect on hydrolysis of fibrin clots in a bull and a man with varying fibrinolytic systems].[肝素对具有不同纤维蛋白溶解系统的公牛和人的纤维蛋白凝块水解的影响]
Ukr Biokhim Zh (1978). 1997 Sep-Dec;69(5-6):109-16.
6
MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.补体系统的 MASP-1 改变了血栓的纤溶行为。
Mol Immunol. 2019 Oct;114:1-9. doi: 10.1016/j.molimm.2019.07.005. Epub 2019 Jul 17.
7
Mechanisms of thrombus formation and lysis.血栓形成与溶解的机制。
Ann Emerg Med. 1988 Nov;17(11):1138-47. doi: 10.1016/s0196-0644(88)80059-3.
8
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.纤维蛋白溶解的分子机制及其在纤维蛋白特异性溶栓治疗中的应用。
J Cell Biochem. 1987 Feb;33(2):77-86. doi: 10.1002/jcb.240330202.
9
[Plasminogen activation and regulation of fibrinolysis].[纤溶酶原激活与纤维蛋白溶解的调节]
Nihon Rinsho. 2014 Jul;72(7):1218-23.
10
Plasminogen-binding proteins as an evasion mechanism of the host's innate immunity in infectious diseases.纤溶酶原结合蛋白作为感染性疾病中宿主固有免疫逃避的机制。
Biosci Rep. 2018 Oct 2;38(5). doi: 10.1042/BSR20180705. Print 2018 Oct 31.

引用本文的文献

1
Endothelial cell source dictates the expression and release of fibrinolytic markers in a proinflammatory environment.在内皮细胞源决定了促炎环境中纤溶标志物的表达和释放。
Res Pract Thromb Haemost. 2025 Jun 11;9(5):102929. doi: 10.1016/j.rpth.2025.102929. eCollection 2025 Jul.
2
Profound Properties of Protein-Rich, Platelet-Rich Plasma Matrices as Novel, Multi-Purpose Biological Platforms in Tissue Repair, Regeneration, and Wound Healing.富含蛋白质、富含血小板的血浆基质在组织修复、再生和伤口愈合中的新型多用途生物平台的深远特性。
Int J Mol Sci. 2024 Jul 19;25(14):7914. doi: 10.3390/ijms25147914.
3
CHI3L1 on fibrinolytic system imbalance in chronic rhinosinusitis with nasal polyp.

本文引用的文献

1
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation.ProCPU 由(主要)人单核细胞和巨噬细胞表达,其表达在分化和激活状态之间存在差异。
Int J Mol Sci. 2023 Feb 13;24(4):3725. doi: 10.3390/ijms24043725.
2
The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.COVID-19 中纤溶反应不佳是由高水平 PAI-1 决定的。
J Thromb Haemost. 2022 Oct;20(10):2394-2406. doi: 10.1111/jth.15806. Epub 2022 Jul 21.
3
Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.
纤溶系统失衡与鼻息肉慢性鼻-鼻窦炎相关中的 CHI3L1。
Front Immunol. 2024 Jun 21;15:1410948. doi: 10.3389/fimmu.2024.1410948. eCollection 2024.
4
The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation.纤维蛋白溶解因子在炎症引起的骨质破坏中的作用。
Cells. 2024 Mar 15;13(6):516. doi: 10.3390/cells13060516.
激活的血小板和血小板微粒上细胞因子 XIII 依赖激活机制的表面暴露。
J Thromb Haemost. 2022 May;20(5):1223-1235. doi: 10.1111/jth.15668. Epub 2022 Feb 21.
4
Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.SARS-CoV-2 相关 COVID-19 呼吸衰竭患者应用阿替普酶的研究:一项先锋性、快速适应、实用、随机对照试验。
Chest. 2022 Mar;161(3):710-727. doi: 10.1016/j.chest.2021.09.024. Epub 2021 Sep 27.
5
Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation.单核细胞暴露因子ⅩⅢ - A并稳定血栓以抵抗纤维蛋白溶解降解。
Int J Mol Sci. 2021 Jun 19;22(12):6591. doi: 10.3390/ijms22126591.
6
Interplay between inflammation and thrombosis in cardiovascular pathology.心血管病理学中的炎症与血栓形成的相互作用。
Nat Rev Cardiol. 2021 Sep;18(9):666-682. doi: 10.1038/s41569-021-00552-1. Epub 2021 May 6.
7
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.一种在多种蛋白酶抑制物中起作用的丝氨酸蛋白酶抑制剂:纤溶酶原激活物抑制剂-1在血栓炎症和心血管疾病中的核心作用
Front Cardiovasc Med. 2021 Apr 16;8:653655. doi: 10.3389/fcvm.2021.653655. eCollection 2021.
8
Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study.COVID-19 危重症患者的凝血、血管内皮功能和纤溶生物标志物:一项单中心前瞻性纵向研究。
J Thromb Haemost. 2021 Jun;19(6):1546-1557. doi: 10.1111/jth.15327. Epub 2021 May 1.
9
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.内皮功能障碍和免疫血栓形成是 COVID-19 的关键发病机制。
Nat Rev Immunol. 2021 May;21(5):319-329. doi: 10.1038/s41577-021-00536-9. Epub 2021 Apr 6.
10
Fibrinolysis: A Primordial System Linked to the Immune Response.纤维蛋白溶解:与免疫反应相关的原始系统。
Int J Mol Sci. 2021 Mar 26;22(7):3406. doi: 10.3390/ijms22073406.